New rabies shot combo tested in kids – could replace current treatment
NCT ID NCT07342257
First seen Jan 20, 2026 · Last updated Apr 30, 2026 · Updated 16 times
Summary
This study tested a new medicine called SYN023 (made of two antibodies) given with the rabies vaccine to healthy children and teens under 18. The goal was to see if it is safe and works well to prevent rabies after a possible exposure. Participants received either SYN023 or a standard treatment, plus the rabies vaccine over several weeks. The study is complete and involved 108 volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES POST-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yuping Dong Autonomous County Center for Disease Control and Prevention
Tongren, Guizhou, 554000, China
Conditions
Explore the condition pages connected to this study.